Biodesix Inc at Morgan Stanley Global Healthcare Conference Transcript
Hi, everyone. My name is Yuko Oku, and I'm on the Life Science Tools and Diagnostics team at Morgan Stanley. Before we begin, I'd like to remind our listeners that important disclosure information can be found at morganstanley.com/research disclosures. If you have any questions, please reach out to your Morgan Stanley sales reps. It's my pleasure today to host Biodesix, and speaking on behalf of the company, CEO, Scott Hutton. Thank you for joining us today.
Yeah. Thank you, Yuko.
Questions & Answers
Maybe to start, if you could begin by highlighting some Biodesix's key accomplishments this year and what you're most excited about as we head into '24.
Yeah. That's a great question. We've had a great 2023 thus far. Most recently, in our recent earnings call, we're really proud to demonstrate and share 75% test volume growth,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
